H. Iida et al., Attenuated additional hypocapnic constriction, but not hypercapnic dilation, of spinal pial arterioles during spinal ropivacaine, ANESTH ANAL, 89(6), 1999, pp. 1510-1513
Citations number
21
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Ropivacaine constricts spinal vessels. Because the CO2 response of spinal v
essels is similar to that of cerebral vessels, we tested to see if hypocapn
ia would cause further spinal vasoconstriction during ropivacaine administr
ation. In 12 pentobarbital-anesthetized dogs, spinal pial arteriolar diamet
er was measured using a closed spinal window preparation. Either ropivacain
e solution (0.1%; n = 6) or artificial cerebrospinal fluid (n = 6) was infu
sed continuously into the spinal window. After a period of hypocapnia (Paco
(2), 20-25 mm Hg) had been induced, inspired CO2 levels were adjusted to pr
oduce normocapnia (35-40 mm Hg) followed by hypercapnia (55-60 mm Hg). When
the desired Pace, was reached measurements were made of the arteriolar dia
meter and physiological variables. During normocapnia, ropivacaine infusion
produced a significant constriction of pial arterioles,whereas artificial
cerebrospinal fluid caused no change. Hypocapnia induced a much smaller (al
most nonexistent) additional vasoconstriction in the ropivacaine group than
in the control group (P < 0.01). The final hypercapnic vasodilation was so
mewhat greater during ropivacaine (P < 0.05 versus control group). Topical
ropivacaine induced no change in hemodynamic variables. We conclude that hy
pocapnia of the magnitude tested did not cause further constriction in spin
al vessels during spinal ropivacaine. Implications: During topical applicat
ion of the local anesthetic ropivacaine in dogs, hypocapnia (Paco(2) 20-25
mm Hg) induced almost no additional constriction of spinal arterioles, and
the hypercapnic vasodilation was maintained. These data suggest that an add
itional constriction in spinal vessels is unlikely when hypocapnia occurs d
uring spinal ropivacaine.